Evidence map›Paper›PMID 24252214›Full record

ArticleActa neuropathologica communications2013

Evidence of aquaporin involvement in human central pontine myelinolysis.

Bogdan F Gh Popescu, Reem F Bunyan, Yong Guo, Joseph E Parisi, Vanda A Lennon, Claudia F Lucchinetti

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. [Hyponatremia : Etiology, diagnosis and acute therapy].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Central Pontine Myelinosis and Osmotic Demyelination Syndrome.Deutsches Arzteblatt international · 2019
    Review
  15. Article
  16. Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.International journal of molecular sciences · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Bogdan F Gh PopescuDepartment Anatomy and Cell Biology, University of Saskatchewan, Saskatoon, SK, Canada. bogdan.popescu@usask.ca.
Reem F Bunyan
Yong Guo
Joseph E Parisi
Vanda A Lennon
Claudia F Lucchinetti
Mayo Clinic · USKing Fahad Specialist Hospital · SAMayo Clinic in Arizona · USUniversity of Saskatchewan · CA

Funding

Mechanisms of Multiple Sclerosis Tissue PathologyR01NS049577 · NINDS · MAYO CLINIC ROCHESTER · PI LUCCHINETTI, CLAUDIA F. · 2006 to 2012
$2.3M
NINDS NIH HHS R01-NS049577-01-A2
6 · The paper itself

Abstract

backgroundCentral pontine myelinolysis (CPM) is a demyelinating disorder of the central basis pontis that is often associated with osmotic stress. The aquaporin water channels (AQPs) have been pathogenically implicated because serum osmolarity changes redistribute water and osmolytes among various central nervous system compartments.

resultsWe characterized the immunoreactivity of aquaporin-1 and aquaporin-4 (AQP1 and AQP4) and associated neuropathology in microscopic transverse sections from archival autopsied pontine tissue from 6 patients with pathologically confirmed CPM. Loss of both AQP1 and AQP4 was evident within demyelinating lesions in four of the six cases, despite the presence of glial fibrillary acidic protein (GFAP)-positive astrocytes. Lesional astrocytes were small, and exhibited fewer and shorter processes than perilesional astrocytes. In two of the six cases, astrocytes within demyelinating lesions exhibited increased AQP1 and AQP4 immunoreactivities, and gemistocytes and mitotic astrocytes were numerous. Blinded review of medical records revealed that all four cases lacking lesional AQP1 and AQP4 immunoreactivities were male, whereas the two cases with enhanced lesional AQP1 and AQP4 immunoreactivities were female.

conclusionsThis report is the first to establish astrocytic AQP loss in a subset of human CPM cases and suggests AQP1 and AQP4 may be involved in the pathogenesis of CPM. Further studies are required to determine whether the loss of AQP1 and AQP4 is restricted to male CPM patients, or rather may be a feature associated with specific underlying precipitants of CPM that may be more common among men. Non-rodent experimental models are needed to better clarify the complex and dynamic mechanisms involved in the regulation of AQPs in CPM, in order to determine whether it occurs secondary to the destructive disease process, or represents a compensatory mechanism protecting the astrocyte against apoptosis.

Indexed as

AdultAgedAquaporin 1Aquaporin 4AstrocytesCell SizeFemaleGlial Fibrillary Acidic ProteinHumansImmunohistochemistryMaleMiddle AgedMyelinolysis, Central PontinePonsSex CharacteristicsYoung AdultAQP1 protein, humanAQP4 protein, humanAquaporin 1Aquaporin 4Glial Fibrillary Acidic Protein

Identifiers

PMID24252214
PMCPMC3893459
OpenAlexW2148399770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.